Association Between Hepatitis B and Hepatocellular Carcinoma Recurrence in Patients Undergoing Liver Transplantation

Transplantation Proceedings

Volumn 40, Issue 5, 2008, Pages 1511-1517

  Kiyici, M ^a   Yilmaz, M ^a   Akyildiz, M ^a   Arikan, C ^a   Aydin, U ^a   Sigirli, D ^a   Nart, D ^a   Yilmaz, F ^a   Ozacar, T ^a   Karasu, Z ^a   Kilic, M ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ANTIVIRUS AGENT; CYCLOSPORIN; ENTECAVIR; HEPATITIS B ANTIBODY; IMMUNOSUPPRESSIVE AGENT; LAMIVUDINE; METHYLPREDNISOLONE; STEROID; TACROLIMUS;

ADULT; ARTICLE; CANCER INVASION; CANCER RECURRENCE; COHORT ANALYSIS; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPHYLAXIS; RECURRENT VIRUS INFECTION; RISK FACTOR; STATISTICAL ANALYSIS; SURVIVAL RATE; SURVIVAL TIME; TUMOR DIFFERENTIATION; TUMOR VOLUME;

ADULT; AGED; CADAVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS B; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PREVALENCE; RECURRENCE; RETROSPECTIVE STUDIES; TISSUE DONORS;

EID: 45449095203     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.03.156     Document Type: Article

References (32)

1. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334 (1996) 693
2. Figueras J., Jaurrieta E., Valls C., et al. Survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma: a comparative study. Hepatology 25 (1997) 1485
3. Starzl T.E., Demetris A.J., and Van Thiel D. Liver transplantation (2). N Engl J Med 321 (1989) 1092
4. Yi N.J., Suh K.S., Cho J.Y., et al. Recurrence of hepatitis B is associated with cumulative corticosteroid dose and chemotherapy against hepatocellular carcinoma recurrence after liver transplantation. Liver Transpl 13 (2007) 451
5. Montalto G., Cervello M., Giannitrapani L., et al. Epidemiology, risk factors, and natural history of hepatocellular carcinoma. Ann N Y Acad Sci 963 (2002) 13
6. Parkin D.M., Bray F.I., and Devesa S.S. Cancer burden in the year 2000. The global picture. Eur J Cancer 37 suppl 8 (2001) S4
7. Yao F.Y., Ferrell L., Bass N.M., et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33 (2001) 1394
8. Akyildiz M., Karasu Z., Zeytunlu M., et al. Adefovir dipivoxil therapy in liver transplant recipients for recurrence of hepatitis B virus infection despite lamivudine plus hepatitis B immunoglobulin prophylaxis. J Gastroenterol Hepatol 22 (2007) 2130
9. Lok A.S.F. Prevention of recurrent hepatitis B post-liver transplantation. Liver Transpl 8 (2002) S67
10. Terrault N.A., and Vyas G. Hepatitis B immune globulin preparations and use in liver transplantation. Clin Liver Dis 7 (2003) 537
11. Wong S.N., Reddy K.R., Keeffe E.B., et al. Comparison of clinical outcomes in chronic hepatitis B liver transplant candidates with and without hepatocellular carcinoma. Liver Transpl. 13 (2007) 334
12. Schlitt H.J., Neipp M., Weimann A., et al. Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation. J Clin Oncol 17 (1999) 324
13. Merli M., Nicolini G., Gentili F., et al. Predictive factors of outcome after liver transplantation in patients with cirrhosis and hepatocellular carcinoma. Transplant Proc 37 (2005) 2535
14. Roayaie S., Schwartz J.D., Sung M.W., et al. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl 10 (2004) 534
15. Wong D.K., Yuen M.F., Poon R.T., et al. Quantification of hepatitis B virus covalently closed circular DNA in patients with hepatocellular carcinoma. J Hepatol 45 (2006) 553
16. Ou D.P., Yang L.Y., Huang G.W., et al. Clinical analysis of the risk factors for recurrence of HCC and its relationship with HBV. World J Gastroenterol 11 (2005) 2061
17. Murakami Y., Saigo K., Takashima H., et al. Large scaled analysis of hepatitis B virus (HBV) DNA integration in HBV related hepatocellular carcinomas. Gut 54 (2005) 1162
18. Thorgeirsson S.S., and Grisham J.W. Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31 (2002) 339
19. Horikawa I., and Barrett J.C. cis-Activation of the human telomerase gene (hTERT) by the hepatitis B virus genome. J Natl Cancer Inst 93 (2001) 1171
20. Paterlini-Brechot P., Saigo K., Murakami Y., et al. Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene. Oncogene 22 (2003) 3911
21. Meyerson M. Role of telomerase in normal and cancer cells. J Clin Oncol 18 (2000) 2626
22. Cougot D., Neuveut C., and Buendia M.A. HBV induced carcinogenesis. J Clin Virol 34 suppl 1 (2005) S75
23. Chan H.L., and Sung J.J. Hepatocellular carcinoma and hepatitis B virus. Semin Liver Dis 26 (2006) 153
24. Fang Z.L., Ling R., Wang S.S., et al. HBV core promoter mutations prevail in patients with hepatocellular carcinoma from Guangxi, China. J Med Virol 56 (1998) 18
25. Baptista M., Kramvis A., and Kew M.C. High prevalence of 1762(T) 1764(A) mutations in the basic core promoter of hepatitis B virus isolated from black Africans with hepatocellular carcinoma compared with asymptomatic carriers. Hepatology 29 (1999) 946
26. Boutwell R.K. The function and mechanism of promoters of carcinogenesis. CRC Crit Rev Toxicol 2 (1974) 419
27. Hildt E., Munz B., Saher G., et al. The PreS2 activator MHBs(t) of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice. EMBO J 21 (2002) 525
28. Kamiyama T., Takahashi M., Nakagawa T., et al. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma. Ann Surg 244 (2006) 451
29. Marubashi S., Dono K., Sugita Y., et al. Alpha-fetoprotein Mrna detection in peripheral blood for prediction of hepatocellular carcinoma recurrence after liver transplantation. Transplant Proc 38 (2006) 3640
30. Wu X.Z., and Yu X.H. Bone marrow cells: the source of hepatocellular carcinoma?. Med Hypotheses 69 (2007) 36
31. Wu X.Z., and Chen D. Origin of hepatocellular carcinoma: role of stem cells. J Gastroenterol Hepatol 21 (2006) 1093
32. Stone M.J., Fulmer J.M., and Klintmalm G.B. Transplantation for primary hepatic malignancy. In: Busuttil R.W., and Klintmalm G.K. (Eds). Transplantation of the Liver (2005), Saunders, Philadelphia, Penn 211